Miscellaneous
Guidelines, prescribing information and patient websites alike all say that lifestyle interventions are the first line of treatment for diabetes, and that pharmacotherapies should be considered as adjunct therapies alongside these. But there is currently no consensus on what these lifestyle interventions should actually be. Should they include a specific diet, exercise type or exercise frequency? In another Unanswered Questions episode, we speak to Professor Jaakko Tuomilehto of the University of Helsinki for his advice on this area of unmet clinical need. For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. Disclosures: Prof. Jaakko Tuomilehto declares the following: Shareholder: Orion pharma Consultant: Eli Lilly All conflicts of interest have been mitigated prior to this activity. Funding statement: Funding statement: This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S, have had no influence on the content of this education.